CytoDyn Inc. Cash And Cash Equivalents At Carrying Value

• CytoDyn Inc. showed an increase of +282.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
• XBRL data for this metric is available from 2003 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2003 to 2025), CytoDyn Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 367,503.5%.
• Historical annual values: Fiscal year 2025: $11.90 million | Fiscal year 2024: $3.11 million | Fiscal year 2023: $2.54 million | Fiscal year 2022: $4.23 million | Fiscal year 2021: $33.94 million | Fiscal year 2020: $14.28 million | Fiscal year 2019: $2.61 million | Fiscal year 2018: $1.23 million | Fiscal year 2017: $1.78 million | Fiscal year 2016: $9.64 million | Fiscal year 2015: $1.05 million | Fiscal year 2014: $4.89 million | Fiscal year 2013: $603.7 thousand | Fiscal year 2012: $285.0 thousand | Fiscal year 2011: $1.04 million | Fiscal year 2010: $700.5 thousand | Fiscal year 2003: $3.2 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026